Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 17, 2026
Why Is KLA Corporation (KLAC) Stock Down -2.29% Today?

Why Is KLA Corporation (KLAC) Stock Down -2.29% Today?

Key Takeaways

  • KLA Corporation shares fell 2.29% on Wednesday, closing at $219.37, extending a multi-session decline for the semiconductor equipment giant.
  • The primary catalyst was a broader rotation out of high-valuation semiconductor names as investors reassess AI-driven capital expenditure assumptions.
  • Renewed concerns over U.S. export controls targeting advanced chip-making equipment, particularly given KLA's significant China revenue exposure, weighed on sentiment.
  • Insider selling activity by the CEO and CFO in recent weeks added a layer of caution among retail and institutional investors.
  • Trading volume surged to approximately 9.3 million shares, well above the recent daily average, signaling conviction behind the selloff.
  • Investors now turn their attention to KLA's upcoming fiscal fourth-quarter earnings report, scheduled for July 28, as the next major catalyst.

Opening Summary

KLAC, the stock of KLA Corporation — a dominant force in semiconductor process control and yield management equipment — declined 2.29% in Wednesday's trading session, closing at $219.37 compared to the prior session's close of $224.50. The $5.13 drop marked the second consecutive day of losses for the Milpitas, California-based company, which designs and manufactures inspection, metrology, and data analytics systems used by the world's largest chipmakers. The move came amid a challenging backdrop for semiconductor equipment stocks, with investors rotating away from richly valued names tied to the artificial intelligence infrastructure buildout.

Broader Semiconductor Sector Weakness Drives the Decline

The most immediate driver behind KLAC's decline was a continuation of the selling pressure that has gripped the semiconductor equipment sector in recent sessions. After a powerful rally earlier in 2026 that saw KLA shares surge well above $300, the stock has entered a corrective phase as institutional investors reassess whether AI-related demand and capital spending expectations have been fully priced into wafer fabrication equipment names. The Technology Equipment sector broadly underperformed the wider market on Wednesday, with peers such as AMAT and LRCX also facing headwinds, confirming that the weakness was sector-driven rather than company-specific.

Geopolitical and Export Control Overhang

Compounding the sector-wide pressure, renewed focus on U.S.-China trade tensions and potential tightening of export controls on advanced semiconductor equipment added a layer of uncertainty. KLA derives a substantial portion of its revenue from international markets, with China alone accounting for approximately 42% of total revenue in recent quarters. Any escalation in restrictions on the shipment of high-end inspection and metrology tools to Chinese foundries directly threatens KLA's revenue visibility. Reports of ongoing discussions within the U.S. Department of Commerce regarding stricter controls on gate-all-around transistor and high-bandwidth memory technologies have kept this risk firmly in the spotlight, prompting some institutional investors to reduce exposure preemptively.

Insider Selling and Valuation Concerns

Adding to the cautious tone, recent regulatory filings revealed notable insider selling activity at KLAC. CEO Richard P. Wallace sold approximately $10 million worth of shares in June, while CFO Bren D. Higgins disposed of roughly $7.36 million in stock in early July under a pre-arranged Rule 10b5-1 trading plan. While such sales do not necessarily signal a deterioration in business fundamentals, they can influence near-term sentiment, particularly when a stock is already under pressure. Separately, KLA's valuation — trading at roughly 62 times trailing earnings and at a significant premium to its historical five-year average forward P/E ratio — has made the stock vulnerable to multiple compression as macroeconomic uncertainty and hawkish interest rate expectations prompt a rotation out of high-multiple growth names.

Market Context and Trading Activity

Wednesday's session saw KLAC volume spike to approximately 9.3 million shares, substantially above the average daily volume observed in recent weeks. The elevated turnover underscored the conviction behind the selling and suggested that institutional portfolio adjustments were underway. The decline occurred even as broader market indices posted modest gains, highlighting the stock-specific and sector-specific nature of the pressure. From a technical standpoint, KLA shares have now breached their 50-day simple moving average, a level that had previously provided support during pullbacks earlier in the year. The stock's 200-day moving average, situated near $176, represents the next widely watched technical floor.

Trending AI Robots

In volatile market environments like the current one, traders increasingly turn to automated strategies to navigate price swings with discipline. Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that have demonstrated strong performance under prevailing market conditions. With hundreds of bots covering thousands of tickers — including semiconductor names like KLAC — the platform highlights only those strategies that are currently excelling, whether through swing trading, trend following, or mean-reversion approaches. Each bot varies by strategy, timeframe, and risk profile, allowing traders to identify tools aligned with their individual objectives. Explore the Trending AI Robots page to see which algorithms are adapting best to today's market dynamics.

What Comes Next for KLAC

The next major catalyst for KLAC arrives on July 28, when the company is scheduled to report its fiscal fourth-quarter 2026 results after the market close. Consensus estimates project earnings per share of approximately $1.00 on revenue of roughly $3.61 billion, representing year-over-year growth. Beyond the headline numbers, investors will scrutinize management's forward guidance for any signs that wafer fab equipment spending — particularly from leading-edge logic and memory customers — is sustaining its momentum or beginning to moderate. Key risks heading into the print include the trajectory of China-related revenue, the pace of AI infrastructure investment, and any updates on the competitive landscape in process control. With the stock trading well off its 52-week high, the earnings report will be pivotal in determining whether the recent pullback represents a buying opportunity or the start of a deeper re-rating.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: KLAC

Contributor

<p>Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years&nbsp;developing&nbsp;his proprietary trading and quantitative algorithms (now Tickeron&rsquo;s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional,&nbsp;sophisticated stock market analysis capabilities to retail investors via&nbsp;an easy-to-use interface.</p>


KLAC in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 28, 2026

KLAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 33 cases where KLAC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where KLAC's RSI Oscillator exited the oversold zone, of 11 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where KLAC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KLAC advanced for three days, in of 345 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KLAC as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KLAC turned negative on July 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

KLAC moved below its 50-day moving average on July 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KLAC crossed bearishly below the 50-day moving average on July 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KLAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KLAC entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KLAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: KLAC's P/B Ratio (40.816) is very high in comparison to the industry average of (8.521). P/E Ratio (54.128) is within average values for comparable stocks, (191.168). Projected Growth (PEG Ratio) (1.894) is also within normal values, averaging (1.595). Dividend Yield (0.004) settles around the average of (0.006) among similar stocks. P/S Ratio (19.268) is also within normal values, averaging (37.902).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 65.22B. The market cap for tickers in the group ranges from 555.66K to 663.18B. ASML holds the highest valuation in this group at 663.18B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 9%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 53%. AXTI experienced the highest price growth at 60%, while SMTK experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was -40% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 32
Price Growth Rating: 42
SMR Rating: 74
Profit Risk Rating: 62
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
KLAC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of process control and yield management solutions for the semiconductor and related nanoelectronics industries

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
One Technology Drive
Phone
+1 408 875-3000
Employees
15200
Web
https://www.kla.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.